Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on June 4, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 4, 2025
BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
EIN Presswire
·
June 4, 2025
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies MUNICH, BAYERN, GERMANY, June 4, 2025 /EINPresswire.com/ -- Paving the Way for European Clinical Entry and Global Technology Transfer …
Digital Breast Tomosynthesis (DBT) Equipment Market to Grow from USD 3.26 Billion in 2025 to USD 7.66 Billion by 2035
EIN Presswire
·
June 4, 2025
Digital Breast Tomosynthesis Market to Reach USD 7.66 Billion by 2035 at 8.9% CAGR NEW YORK, DE, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The global digital breast tomosynthesis (DBT) equipment market is estimated to be valued at USD 3.26 …
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
GlobeNewswire
·
June 4, 2025
SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech …
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 2:00 p.m. ET. The webcast …
NeuroPace Secures Up to $75 Million in Debt Financing
GlobeNewswire
·
June 4, 2025
MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has entered into a new $75 million credit …
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its …
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
GlobeNewswire
·
June 4, 2025
GERMANTOWN, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
BRISBANE, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, …
Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio for Development in Autoimmune Diseases
GlobeNewswire
·
June 4, 2025
Advances Cullinan’s leadership in T cell engager (TCE) development for autoimmune diseases with both a CD19 TCE and BCMA TCE in its pipeline Strengthens Cullinan portfolio of autoimmune programs with the opportunity to address a broader range of diseases …
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics
GlobeNewswire
·
June 4, 2025
See-Mode’s commercially available AI-powered ultrasound detection, characterization, and reporting solutions for thyroid and breast will be integrated into RadNet’s DeepHealth population health solutions Real-world deployment of See-Mode’s FDA-approved …
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
GlobeNewswire
·
June 4, 2025
GAITHERSBURG, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Rebud Expands Access to Legal Cannabis in Highland Park with Focus on Community and Convenience
EIN Presswire
·
June 4, 2025
Los Angeles dispensary emphasizes same-day delivery, trusted brands, and in-store service to serve neighborhood demand. LOS ANGELES, CA, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- As cannabis access continues to evolve in Los Angeles, Rebud Weed …
Rebud Weed Dispensary & Delivery Enhances Local Cannabis Access in North Hollywood
EIN Presswire
·
June 4, 2025
North Hollywood’s Rebud Dispensary Continues to Serve the Community with Same-Day Delivery and Trusted Brands NORTH HOLLYWOOD, CA, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- As California’s cannabis retail sector continues to mature, Rebud Weed …
Rebud Weed Dispensary & Delivery – Sylmar Enhances Cannabis Access with Delivery and In-Store Options
EIN Presswire
·
June 4, 2025
With a focus on accessibility and trusted brands, Rebud Sylmar expands its footprint in the San Fernando Valley cannabis market SYLMAR, CA, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- As the cannabis retail sector continues to evolve across …
NJ Top Docs Approves Dr. Janet M. Neigel of EltraSelf Awarded As 2025 Top Doctor
EIN Presswire
·
June 4, 2025
NJ Top Docs has reviewed and approved Dr. Janet M. Neigel of EltraSelf based on merit for 2025. FLORHAM PARK, NJ, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- NJ Top Docs proudly recognizes Dr. Janet M. Neigel, a board-certified ophthalmologist at …
ABL Diagnostics to Present Breakthrough Scientific Data at the European Meeting on HIV & Hepatitis 2025
EIN Presswire
·
June 4, 2025
Featuring New Advances in Automated Bioinformatics and HIV Drug Resistance Detection Using Next-Generation Sequencing WOIPPY, FRANCE, June 4, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in …
Regenerative Medicine Market to Reach USD 22.05 Billion by 2035, Growing at 8.4% CAGR
EIN Presswire
·
June 4, 2025
Regenerative Medicine Industry Forecast: USD 22.05 Billion by 2035 with 8.4% CAGR NEW YORK, DE, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The global regenerative medicine market is estimated to be valued at USD 9.8 billion in 2025 and is …
Salt Cave Design Industry Thrives as Dr. Margaret Smiechowski Helps Entrepreneurs Build Their Wellness Dreams
EIN Presswire
·
June 4, 2025
Salt cave expert Dr. Margaret Smiechowski helps entrepreneurs launch wellness businesses with custom salt room and salt cave design and construction services. ORLEANS, MA, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The growing demand for natural …
As Interest Grows for New Agents to Treat Thalassemia, Hematologists Begin Early Identification of Ideal Patients for Gene Therapies Vs. New Therapeutic Options
GlobeNewswire
·
June 4, 2025
EXTON, PA, June 04, 2025 (GLOBE NEWSWIRE) -- Despite the promise of new curative strategies for beta thalassemia, such as Casgevy (Vertex) and Zynteglo (bluebird bio), most transfusion-dependent thalassemia patients remain tethered to long-term transfusion …